Edgewise Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Edgewise Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Edgewise Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 2.8K %, a 28.6% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.8K +622 +28.6% Sep 30, 2024
Q2 2024 2.6K +182 +7.51% Jun 30, 2024
Q1 2024 2.39K -147 -5.8% Mar 31, 2024
Q4 2023 2.12K -426 -16.7% Dec 31, 2023
Q3 2023 2.17K -558 -20.4% Sep 30, 2023
Q2 2023 2.42K -438 -15.4% Jun 30, 2023
Q1 2023 2.54K -654 -20.5% Mar 31, 2023
Q4 2022 2.54K -1.31K -34.1% Dec 31, 2022
Q3 2022 2.73K -1.47K -34.9% Sep 30, 2022
Q2 2022 2.85K Jun 30, 2022
Q1 2022 3.19K Mar 31, 2022
Q4 2021 3.86K Dec 31, 2021
Q3 2021 4.2K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.